UTHR United Therapeutics
$541.62 +0.97%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
+0.97%
YTD
+18.60%
P/E
18.43
P/B
2.96
ROE
20.2%
Div yield
—
Beta
0.21
Market cap
$24.2B
RSI (14)
59
Next earnings
Oct 27, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$537.19
Close
$541.62
VWAP (n/a)
—
Day high
$546.16
Day low
$527.33
Volume
1.2M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
United Therapeutics Just Sent Liquidia Stock Lower After Patent Battle
Yahoo Finance · Oct 1
Stocks making big moves yesterday: United Therapeutics, Moderna, Jabil, Concentrix, and FactSet
Yahoo Finance · Oct 1
LQDA Stock On Track For Worst Week Ever As Analysts Say The Yutrepia Patent Loss Clouds Its Path
Yahoo Finance · Oct 1
UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13%
Yahoo Finance · Oct 1
1 Mid-Cap Stock to Research Further and 2 That Underwhelm
Yahoo Finance · Oct 1
United Therapeutics Soars 13% as Court Rules Yutrepia Infringes Its Patent
Yahoo Finance · Oct 1
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Sep 8, 2026 View → 8-K Aug 5, 2026 View → 10-Q Aug 5, 2026 View → 8-K Jul 23, 2026 View → 8-K Jun 29, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell UTHR. Try it in the Lab to size a position and see the risk.